{"disease":{"id":"proctitis","name":"Proctitis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":9,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"phenylmercuric-nitrate","indication_name":"Proctitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"phenylmercuric nitrate","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"phenylmercuric nitrate","quality_score":null,"revenue":null,"mechanism":"Phenylmercuric nitrate works by releasing mercury ions that have antimicrobial and anti-inflammatory properties."},{"drug_id":"ferric-oxide","indication_name":"Proctitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Iron Oxide","generic_name":"ferric oxide","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":19,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Chronic ulcerative proctitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Proctitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"mesalazine","indication_name":"Chronic ulcerative proctitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rowasa","generic_name":"Mesalazine","company_name":"Meda Pharms","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"Aminosalicylate [EPC]","quality_score":65,"revenue":null,"mechanism":"Rowasa works by blocking the production of prostaglandins, which are chemicals that cause inflammation in the rectum and colon."},{"drug_id":"phenylephrine","indication_name":"Proctitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sudafed PE","generic_name":"phenylephrine","company_name":"Generic (multiple manufacturers)","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor","drug_class":"Alpha-1 adrenergic agonist (decongestant/vasopressor)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"phenylephrine-bitartrate","indication_name":"Proctitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Phenergan Vc W/ Codeine","generic_name":"PHENYLEPHRINE BITARTRATE","company_name":"ANI Pharmaceuticals","drug_phase":"marketed","molecular_target":"Alpha-1B adrenergic receptor","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"mesa","indication_name":"Chronic ulcerative proctitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"MESA","company_name":"Meda Pharms","drug_phase":"marketed","molecular_target":"Arachidonate 5-lipoxygenase, Peroxisome proliferator-activated receptor gamma, Prostaglandin G/H synthase 1","drug_class":"","quality_score":38,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone","indication_name":"Chronic ulcerative proctitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone","indication_name":"Proctitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"zinc-acetate","indication_name":"Proctitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Galzin","generic_name":"ZINC ACETATE","company_name":"Eton","drug_phase":"marketed","molecular_target":"","drug_class":"zinc acetate","quality_score":37,"revenue":null,"mechanism":""},{"drug_id":"cortisol","indication_name":"Chronic ulcerative proctitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cortisol","indication_name":"Proctitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"pramocaine","indication_name":"Proctitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"pramocaine","company_name":"","drug_phase":"unknown","molecular_target":"Sigma non-opioid intracellular receptor 1, Sodium channel alpha subunits; brain (Types I, II, III), Membrane-associated progesterone receptor component 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":14,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01008423","title":"Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":281,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT01008410","title":"Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":265,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT07061899","title":"The Prevalence of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Patients Suspected of Hemorrhagic Proctosigmoiditis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":214,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT04335617","title":"Micronized Purified Flavonoid- Fraction (MPFF) in the Management of Radiation Proctitis","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Medical University Innsbruck","has_results":false},{"nct_id":"NCT04469686","title":"Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Cristcot LLC","has_results":false},{"nct_id":"NCT05406882","title":"The Effects of Probiotics Combined With Glutamine in the Prevention and Treatment of Radiation Proctitis","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":176,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT06837597","title":"Jianzhong Qushi in Chronic RRI","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":168,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT07378631","title":"Association Between Clinical Subtypes and Prognosis in Radiation Rectal Injury","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT07053761","title":"A Randomized Controlled Trial of Five - Flavor Sophora Flavescens Enteric - Coated Capsules for Radiation - Induced Proctitis After Pelvic Radiotherapy","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":124,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT01016262","title":"Efficacy and Safety Study of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":119,"lead_sponsor_name":"Forest Laboratories","has_results":true},{"nct_id":"NCT01349673","title":"The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmoiditis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":114,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT07248020","title":"A Phase II Single-Arm Study of High-Bioavailability Curcumin as Neoadjuvant Chemoradiotherapy in Mid-to-Low Rectal Cancer: Integrated Clinical and Translational Analysis of Tumor Tissue","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":72,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT04680195","title":"Thalidomide in the Treatment of Chronic Radiation Proctitis With Intractable Bleeding","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":62,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT05489107","title":"New Local Treatment of Radiation-induced Proctitis","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Barmherzige Brüder Vienna","has_results":false},{"nct_id":"NCT06469216","title":"Efficacy of Hyaluronic Acid in Prevention of Acute Radiation Proctitis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07259681","title":"Gut Microbiome in Gynecological Cancer Patients With Pelvic Toxicity: Controls Versus Ozone Treatment. (MicrOzoGineTox)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":38,"lead_sponsor_name":"Bernardino Clavo, MD, PhD","has_results":false},{"nct_id":"NCT06776016","title":"Dietary Supplements to Treat Radiation-Induced Rectal Injury","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":33,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT03521232","title":"A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":27,"lead_sponsor_name":"Entero Therapeutics","has_results":false},{"nct_id":"NCT06776029","title":"Fecal Microbiota Transplantation for Radiation-Induced Proctopathy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}